Homepage - Ophthalmology Advisor
This Domestic Violence Awareness Month, Psychiatry Advisor spoke with Allison Paugh to discuss best practices when encountering cases of suspected IPV during teletherapy.
Novel Lipid Eye Drops Show Promise for Treating Dry Eye
2024年10月28日 · A novel lipid-containing eye drop is noninferior to a commercially available nonlipid comparator in all dry eye parameters measured, according to research published in BMC Ophthalmology.The medication reviewed, (Blink ® Triple Care [BTC], Bausch+Lomb, Inc.) may serve as an effective alternative therapy for patients with dry eye symptoms who would benefit from a lipid-based artificial tear ...
For Central Serous Chorioretinopathy, Wait-and-See No More
K. Patricia Bouweraerts, MM, MA is a science and education writer, editorial designer, and previous optometric assistant. She has written articles and textbook contributions for higher education materials, general interest/news publications, online medical publications, and designs graphics for nonprofits.
Intraocular Lens Choice Dependent on Lifestyle, Expectations ...
2024年10月4日 · Cataract surgeons are responsible for advising patients on a decision that will have lifelong implications. Identifying the intraocular lens (IOL) choice most suited for a particular patient’s lifestyle should be done with the patient’s careful consideration, and full understanding of the portfolio of options before them.
Ophthalmology Advisor Redesign: New Look, Better Access, …
Welcome to the new Ophthalmology Advisor! As you can see, we’ve completely redesigned the site with a sleeker, more modern feel to better fit our top-quality and comprehensive eye care coverage.
Treatment Burden Reduction in Retinal Care a Prime Focus At AAO ...
2024年11月1日 · It was 20 years ago, not quite today, that the first anti-vascular endothelial growth factor (VEGF) agent was approved for ophthalmic use. 1 And while these drugs did create a whole new paradigm for treating age-related macular degeneration (AMD), diabetic macular edema (DME), and other retinal conditions, researchers have not spent the last 20 years resting on their laurels.
FDA Alerts: Ophthalmology Drug and Device Approvals
2024年2月20日 · Drug Regulatory Updates. Susvimo: Diabetic Eye Conditions. The FDA has accepted the application for Susvimo ® (ranibizumab injection, Genentech) to treat diabetic macular edema (DME) and diabetic retinopathy (DR) based on 1-year Pagoda and Pavilion study data. 3 Susvimo is a refillable implant that delivers medication continuously. 3. Based on 2 years of Phase 3 data presented at American ...
Photobiomodulation: An Emerging Dry AMD Treatment
2024年3月20日 · In exudative age-related macular degeneration (wet AMD), significant strides — such as the development of anti-vascular endothelial growth factor (anti-VEGF) therapies — have pushed the treatment possibilities forward and rewritten the likely course of the disease for many patients. However, for most patients, AMD is nonexudative (dry), and treatments for those patients remain largely ...
Dry AMD Study Shows Promise With Low-Level Light Therapy ...
2024年10月16日 · Photobiomodulation (PBM) using a low-level light therapy device is safe and well-tolerated, and can potentially offer both functional and anatomical improvements in patients with dry non-neovascular, nonexudative age-related macular degeneration (dry AMD), according to study results published in Ophthalmology and Therapy. Researchers conducted a preliminary analysis of the safety, tolerability ...
In Glaucoma Management, Less is More - Ophthalmology Advisor
2021年4月23日 · A riddle stands at the center of glaucoma care. Research indicates that, when intraocular pressure (IOP) is substantially lowered, disease progression can be halted. 1 Yet, multiple studies show that, despite adequate lowering of IOP, disease progression still occurs. 2,3 How do we reconcile this apparent paradox? Why do medicated patients continue to progress despite IOPs that are low enough ...